MY127212A - New pyridine-substituted pyrazolopyridine derivatives - Google Patents

New pyridine-substituted pyrazolopyridine derivatives

Info

Publication number: MY127212A
Authority: MY; Malaysia
Prior art keywords: pyrazolopyridine derivatives; new pyridine; disorders; substituted pyrazolopyridine; treatment
Prior art date: 2000-11-22

Application number

MYPI20015302A

Other languages

English (en)

Inventor

Johannes-Peter Stasch Dr

Elisabeth Perzborn Dr

Alexander Straub Dr

Achim Feurer Dr

Cristina Alonso-Alija Dr

Elke Stahl Dr

Klaus Dembowsky Dr

Dietmar Flubacher Dr

Frank Wunder Dr

Stefan Weigand Dr

Dieter Lang Dr

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-22

Filing date

2001-11-20

Publication date

2006-11-30

2001-11-20 Application filed by Bayer Ag filed Critical Bayer Ag

2006-11-30 Publication of MY127212A publication Critical patent/MY127212A/en

Links

-1 pyridine-substituted pyrazolopyridine Chemical class 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
208000035475 disorder Diseases 0.000 abstract 2
AMFYRKOUWBAGHV-UHFFFAOYSA-N 1h-pyrazolo[4,3-b]pyridine Chemical compound C1=CN=C2C=NNC2=C1 AMFYRKOUWBAGHV-UHFFFAOYSA-N 0.000 abstract 1
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
206010020772 Hypertension Diseases 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
201000001880 Sexual dysfunction Diseases 0.000 abstract 1
102000007637 Soluble Guanylyl Cyclase Human genes 0.000 abstract 1
108010007205 Soluble Guanylyl Cyclase Proteins 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
208000028867 ischemia Diseases 0.000 abstract 1
231100000872 sexual dysfunction Toxicity 0.000 abstract 1
230000009424 thromboembolic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

MYPI20015302A 2000-11-22 2001-11-20 New pyridine-substituted pyrazolopyridine derivatives MY127212A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10057753		2000-11-22
DE10131987A DE10131987A1 (de)	2000-11-22	2001-07-02	Neue Pyridin-substituierte Pyrazolopyridinderivate

Publications (1)

Publication Number	Publication Date
MY127212A true MY127212A (en)	2006-11-30

Family

ID=7664122

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI20015302A MY127212A (en)	2000-11-22	2001-11-20	New pyridine-substituted pyrazolopyridine derivatives

Country Status (12)

Country	Link
KR (1)	KR20030065519A (es)
DE (2)	DE10131987A1 (es)
DO (1)	DOP2001000291A (es)
EC (1)	ECSP034616A (es)
GT (1)	GT200100235A (es)
HN (1)	HN2001000261A (es)
MY (1)	MY127212A (es)
PE (1)	PE20020581A1 (es)
RU (1)	RU2003118584A (es)
SV (1)	SV2003000743A (es)
UA (1)	UA74404C2 (es)
ZA (1)	ZA200303887B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102485724B (zh) *	2010-12-06	2015-08-12	中国人民解放军军事医学科学院毒物药物研究所	取代噻吩基吡唑并吡啶类化合物及其医药用途
ES2603028T3 (es)	2011-11-25	2017-02-23	Adverio Pharma Gmbh	Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos
EP3525779B1 (de) *	2016-10-11	2024-06-05	Bayer Pharma Aktiengesellschaft	Kombination enthaltend den sgc stimulator vericuguat und den mineralcorticoid-rezeptor-antagonist finerenone

2001
- 2001-07-02 DE DE10131987A patent/DE10131987A1/de not_active Withdrawn
- 2001-11-09 KR KR10-2003-7006853A patent/KR20030065519A/ko not_active Withdrawn
- 2001-11-09 UA UA2003065752A patent/UA74404C2/uk unknown
- 2001-11-09 DE DE50106655T patent/DE50106655D1/de not_active Expired - Lifetime
- 2001-11-09 RU RU2003118584/04A patent/RU2003118584A/ru not_active Application Discontinuation
- 2001-11-20 DO DO2001000291A patent/DOP2001000291A/es unknown
- 2001-11-20 MY MYPI20015302A patent/MY127212A/en unknown
- 2001-11-21 PE PE2001001161A patent/PE20020581A1/es not_active Application Discontinuation
- 2001-11-21 HN HN2001000261A patent/HN2001000261A/es unknown
- 2001-11-21 SV SV2001000743A patent/SV2003000743A/es unknown
- 2001-11-22 GT GT200100235A patent/GT200100235A/es unknown
2003
- 2003-05-19 ZA ZA200303887A patent/ZA200303887B/en unknown
- 2003-05-21 EC EC2003004616A patent/ECSP034616A/es unknown

Also Published As

Publication number	Publication date
ECSP034616A (es)	2003-06-25
UA74404C2 (uk)	2005-12-15
RU2003118584A (ru)	2004-12-20
PE20020581A1 (es)	2002-07-13
GT200100235A (es)	2002-06-25
KR20030065519A (ko)	2003-08-06
DE10131987A1 (de)	2002-05-23
DOP2001000291A (es)	2002-12-15
HN2001000261A (es)	2002-01-30
ZA200303887B (en)	2004-06-21
SV2003000743A (es)	2003-01-13
DE50106655D1 (de)	2005-08-04

Similar Documents

Publication	Publication Date	Title
MXPA03004500A (es)	2004-05-14	Nuevos derivados de pirazolopiridina sustituidos con piridina.
MXPA04004370A (es)	2004-08-11	Derivados policiclicos de guanina inhibidores de fosfodiesterasa v.
MX2007007220A (es)	2007-08-20	Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos.
UA74419C2 (uk)	2005-12-15	Заміщені піридини та їх застосування як антагоністів рецептору метаботропного глутамату
MXPA05002443A (es)	2005-09-30	Pirazolopiridinas y metodos para elaboracion y uso de las mismas.
MXPA04001889A (es)	2004-06-15	Inhibidores de la alquin-aril fosfodiesterasa-4.
IL155875A0 (en)	2003-12-23	Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
MXPA05002442A (es)	2005-09-30	Imidazolopiridinas y metodos para la elaboracion y uso de las mismas.
MXPA04001891A (es)	2004-06-15	Inhibidores policiclicos de guanina fosfodiesterasa v.
BG103964A (en)	2000-08-31	SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
GB0504828D0 (en)	2005-04-13	Therapeutic agents
AU2003229772A1 (en)	2003-12-02	Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
MXPA03009750A (es)	2004-06-30	Compuestos quimicos.
IL151646A0 (en)	2003-04-10	Use of pyrido[3,2-e]-pyrazinones as inhibitors of phosphodicesterase 5 for treating erectile dysfunction
MXPA03005601A (es)	2004-12-02	Nuevos compuestos y composiciones como inhibidores de catepsina.
CA2474510A1 (en)	2003-09-04	Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
MY128241A (en)	2007-01-31	Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
IS8377A (is)	2006-03-27	Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
MY127212A (en)	2006-11-30	New pyridine-substituted pyrazolopyridine derivatives
WO2002014275A3 (en)	2002-05-30	Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
WO2002014294A3 (en)	2002-06-06	Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
GB9711123D0 (en)	1997-07-23	Novel cyanoguanidines
AR027134A1 (es)	2003-03-12	Derivados de indol.
ATE298742T1 (de)	2005-07-15	Zykloalkenylsulfonamidderivate
EP1400522A4 (en)	2006-04-05	NEW COMPOUNDS FOR THE TREATMENT OF IMPUSE